Navigation Links
New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation
Date:3/5/2009

DALLAS, March 5 /PRNewswire/ -- A study published by Deborah S. Sarnoff, M.D. et al in the February issue of the Journal of Drugs in Dermatology explores the new generation of carbon dioxide (CO2) laser skin resurfacing technologies, specifically, the SmartXide DOT(TM) laser. DOT utilizes a fractional or microablative approach to treating the skin allowing for rapid healing, less downtime and profound results. Dr. Sarnoff is a board certified dermatologist and clinical professor of Dermatology at NYU Medical Center.

As consumers have become savvier to skin care and laser options, the pendulum is swinging back to more result-oriented treatments. With the saturation of non-ablative lasers, skin tightening devices and chemical peels, patients are looking for an alternative treatment that offers exceptional results with fewer treatments and less time in the doctor's office. What these procedures can do in 4-5 treatments, the DOT technology can do in a single treatment and results have been far superior to anything on the market today.

By combining the CO2 laser with a fractionated technique, the latest innovation in skin rejuvenation, DOT (Dermal Optical Thermolysis), has become the optimal choice for active patients desiring significant effects from a single treatment with minimal downtime. Additionally, DOT Therapy is ideal in causing immediate contraction of wrinkles and loose skin, results that non-ablative lasers produce in a time span of about six months.

Dr. Sarnoff's study examined 32 patients ages 33-76 over a six-month period who underwent a single laser resurfacing procedure with the DOT technology. Areas treated included the face, neck, trunk and hands. Results demonstrated over 50% improvement in almost all of the patients. Those treated for wrinkles, hyperpigmentation and sun damage showed over 75% improvement.

Why It Works

The DOT procedure (www.dottherapy.com) precisely delivers CO2 laser energy to targeted areas on the face or non-facial areas like the neck and decolletage, and effectively treats sun damage, wrinkles, fine lines, and acne scarring. Unlike any other skin resurfacing CO2 laser, the DOT system is unique because it ablates a customized pattern of tiny, micro-sized dots, rather than the entire skin surface. This results in the creation of very tiny columns of thermal damage that penetrate deep into the dermis and stimulate the growth of new collagen. The energy is applied in a "fractional" way in which tiny columns of thermal damage are spaced so that tissue between each is spared, which in turn leads to a faster healing process.

The technological advancements in the delivery system of DOT technology allow us to offer patients custom designed treatments tailored to their specific needs and downtime tolerance. "We have found DOT to have a high safety profile, low incidence of adverse side effects and high patient satisfaction," concludes Sarnoff. The ability to rebuild elasticity and collagen density within aged skin has added a tremendous dimension to rejuvenation procedures.

The DOT laser technology literally takes years off the face.


'/>"/>
SOURCE Eclipsemed
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
2. Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
3. Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
4. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
5. TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
6. Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study
7. Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds
8. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
9. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
10. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
11. MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; ... Favor of God; Second Edition” is the creation of published author, Brooks Rathell. , ... opportunity to talk to you about the financial favor of God. Not only does ...
(Date:9/20/2017)... ... ... “Monique”: is the story of Monique, whose mother’s deteriorating physical condition forces the ... has owned four beauty salons and written a book regarding the author’s success in ... , “The doctor’s office was only three blocks away, and she could walk it, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... ... September 19, 2017 , ... PAPA Healthcare, Inc. announced ... called, “PAPA Healthcare helps fill gaps, provide essential insights, and improve productivity.” ... operations by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, ... President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID staff ...
Breaking Medicine News(10 mins):